Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Paganuzzi

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1985
Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancerM Onetto, M Paganuzzi, G B Secco, et al.
Anticancer Research|May 1, 1994
Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastasesM Paganuzzi, M Onetto, M de Paoli, et al.
Minerva Ginecologica|April 1, 1987
[Breast neoplasms: possible prognostic role of steroid receptors]G P Barbi, P Marroni, R Zappa, et al.
Journal of Surgical Oncology|February 1, 1988
Hormone receptors in breast cancer: a conservative determination of receptors' presence in tumor tissue and ipsilateral normal mammary glandF Badellino, G Canavese, A Catturich, et al.
Cancer Detection and Prevention|January 1, 1993
Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluationL Repetto, M Onetto, G Gardin, et al.
Oncology|March 1, 1993
LH-RH analogue treatment in adenocarcinoma of the pancreas: a phase II study. Gruppo Ligure per lo Studio del PancreasA Allegretti, R Lionetto, S Saccomanno, et al.
Oncology|May 1, 1994
Genotypic, phenotypic and biological characterization of a novel human lung adenocarcinoma cell line (LC 89)M Paganuzzi, P Marroni, A Pezzolo, et al.
Leukemia|January 1, 1997
Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemiaG De Rossi, P Marroni, M Paganuzzi, et al.
Oncology|July 1, 1994
Evaluation of cathepsin D as prognostic predictor in breast cancerG P Barbi, E Margallo, M Margiocco, et al.
Oncology|January 1, 1989
Evaluation of the ovarian cancer antigen, Ca-125, as a tumor markerM Onetto, M Bruzzone, P F Conte, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1985
Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancerM Onetto, M Paganuzzi, G B Secco, et al.
Anticancer Research|May 1, 1994
Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastasesM Paganuzzi, M Onetto, M de Paoli, et al.
Minerva Ginecologica|April 1, 1987
[Breast neoplasms: possible prognostic role of steroid receptors]G P Barbi, P Marroni, R Zappa, et al.
Journal of Surgical Oncology|February 1, 1988
Hormone receptors in breast cancer: a conservative determination of receptors' presence in tumor tissue and ipsilateral normal mammary glandF Badellino, G Canavese, A Catturich, et al.
Cancer Detection and Prevention|January 1, 1993
Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluationL Repetto, M Onetto, G Gardin, et al.
Oncology|March 1, 1993
LH-RH analogue treatment in adenocarcinoma of the pancreas: a phase II study. Gruppo Ligure per lo Studio del PancreasA Allegretti, R Lionetto, S Saccomanno, et al.
Oncology|May 1, 1994
Genotypic, phenotypic and biological characterization of a novel human lung adenocarcinoma cell line (LC 89)M Paganuzzi, P Marroni, A Pezzolo, et al.
Leukemia|January 1, 1997
Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemiaG De Rossi, P Marroni, M Paganuzzi, et al.
Oncology|July 1, 1994
Evaluation of cathepsin D as prognostic predictor in breast cancerG P Barbi, E Margallo, M Margiocco, et al.
Oncology|January 1, 1989
Evaluation of the ovarian cancer antigen, Ca-125, as a tumor markerM Onetto, M Bruzzone, P F Conte, et al.
Pageof 3